NAZURA BIOHEALTH
Nazura Biohealth is formed by Elcelyx Therapeutics to focus on the development of Gut Sensory Modulators (GSM) and the product Lovidia. The company was established in 2013 by Alain Baron and is headquartered in San Diego, California.
NAZURA BIOHEALTH
Industry:
Biotechnology Dietary Supplements Pharmaceutical
Founded:
2013-09-04
Address:
San Diego, California, United States
Country:
United States
Total Employee:
1+
Status:
Active
Contact:
858-227-9233
Similar Organizations
Sorrento Therapeutics
Sorrento Therapeutics is focused on the development of proprietary drug therapeutics for addressing unmet medical needs.
Founder
More informations about "Nazura Biohealth"
Nazura Biohealth - Crunchbase Company Profile & Funding
Nazura Biohealth is formed by Elcelyx Therapeutics to focus on the development of Gut Sensory Modulators (GSM) and the product Lovidia. The company was established in 2013 by Alain …See details»
Elcelyx Therapeutics - Crunchbase Company Profile
In September 2013, Elcelyx announced the formation of NaZura BioHealth Inc, a separate company established to focus on the development on non-NewMet …See details»
Nazura Biohealth, Inc. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Nazura Biohealth, Inc. of San Diego, CA. Get the latest business insights from Dun & Bradstreet.See details»
Elcelyx Therapeutics - Craft
In September 2013, Elcelyx announced the formation of NaZura BioHealth Inc, a separate company established to focus on the development on non-NewMet assets. Elcelyx is …See details»
Nazura Biohealth - Crunchbase
Nazura Biohealth is formed by Elcelyx Therapeutics to focus on the development of Gut Sensory Modulators (GSM) and the product Lovidia.See details»
Nazura BioHealth, Inc. - Drug pipelines, Patents, Clinical trials
Explore Nazura BioHealth, Inc. with its drug pipeline, therapeutic area, technology platform, .See details»
Elcelyx Therapeutics spins out NaZura BioHealth
Sep 4, 2013 · Elcelyx Therapeutics has established NaZura BioHealth, a separate company focusing on development of Gut Sensory Modulators (GSM) including lead product Lovidia, a …See details»
NaZura BioHealth Spun-out from Elcelyx Therapeutics to Advance …
SAN DIEGO, Sept. 4, 2013 /PRNewswire/ -- Elcelyx Therapeutics announced today that it has formed NaZura BioHealth, a separate company established to focus on the development of …See details»
Elcelyx creates NaZura BioHealth to develop Lovidia.
Oct 1, 2013 · Elcelyx Therapeutics, San Diego, CA, has formed NaZura BioHealth, a separate company established to focus on the development of Gut Sensory Modulators (GSM) including …See details»
nazura biohealth, inc. News & Press Releases | PR Newswire
Elcelyx Therapeutics announced today that it has formed NaZura BioHealth, a separate company established to focus on the development of Gut Sensory...See details»
NaZura BioHealth - CB Insights
See NaZura BioHealth funding rounds, investors, investments, exits and more. Evaluate their financials based on NaZura BioHealth's post-money valuation and revenue.See details»
Alain D. Baron: Positions, Relations and Network - MarketScreener
May 17, 2011 · Chief Executive Officer at Nazura BioHealth, Inc., Discover Alain D. Baron's known position history, network and 54 relationships. Find out about his known public assets.See details»
Nazura Biohealth - Tech Stack, Apps, Patents & Trademarks
Nazura Biohealth is formed by Elcelyx Therapeutics to focus on the development of Gut Sensory Modulators (GSM) and the product Lovidia.See details»
NaZura BioHealth - Products, Competitors, Financials, Employees ...
NaZura BioHealth is out of business. It is a biopharmaceutical company. The company specializes in the development and production of consumer and pharmaceutical products. The company is …See details»
NaZura BioHealth - CB Insights
Explore {NaZura BioHealth's key management people. Discover current leadership team members including founders, CEO, other executives and board directors.See details»
Taste Receptors in the Gut Identified as New Target for Satiety and ...
Nov 15, 2013 · /PRNewswire/ -- NaZura BioHealth today announced clinical study results indicating that activation of taste receptors in the lower gut can amplify the release...See details»
NaZura’s Lovidia Weight-Loss Supplement Strategy Focused On …
Oct 2, 2013 · NaZura BioHealth, spun out from Elcelyx Therapeutics, will market its Lovidia weight-loss product in 2014 when it launches into the direct-response channel, before …See details»
Designing Effective Individualized Treatment Plans for Your …
Oct 23, 2024 · Drs Fujioka, Ryan, and Church weigh in on developing patient-specific weight loss treatment plans based on desired clinical targets. This activity is intended for family …See details»
Press Releases - Escient pharmaceuticals
May 9, 2018 · SAN DIEGO– (BUSINESS WIRE)–Escient Pharmaceuticals launched today with the completion of a $40 million Series A financing to advance first-in-class G Protein-Coupled …See details»
Escient Pharmaceuticals Launches with $40 Million ... - Business Wire
May 9, 2018 · SAN DIEGO-- ( BUSINESS WIRE )--Escient Pharmaceuticals launched today with the completion of a $40 million Series A financing to advance first-in-class G Protein-Coupled …See details»